ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

McMurray, John J.V.; Adamopoulos, Stamatis; Anker, Stefan D.; Auricchio, Angelo; Böhm, Michael; Dickstein, Kenneth; Falk, Volkmar; Filippatos, Gerasimos; Fonseca, Cândida; Sánchez, Miguel; Jaarsma, Tiny; Køber, Lars; Lip, Gregory Y.H.; Maggioni, Aldo P.; Parkhomenko, Alexander; Pieske, Burkert; Popescu, Bogdan A.; Rønnevik, Per K.; Rutten, Frans H.; Schwitter, Juerg; Seferović, Petar; Stępińska, Janina; Trindade, Pedro T.; Voors, Adriaan A.; Zannad, Faı̈ez; Zeiher, Andreas M.

doi:10.1016/j.repce.2013.10.001

Cited by 218 publications

(395 citation statements)

References 236 publications

(307 reference statements)

Supporting

Mentioning

317

Contrasting

Unclassified

Order By: Relevance

“…20,21 Our data on gender are in agreement with other reports showing that elderly patients hospitalized with HF are mainly women 22 and that patients with HFpEF are older and more often female than those with HFrEF. 1,5,6,8,13 HF patients managed by internists are more likely to have the characteristics of those managed by general practitioners. In the UK, the mean age of HF patients in general practice is 77 years, similar to that of our population.…”

Section: Discussionmentioning

confidence: 99%

“…HF was diagnosed according to European Society of Cardiology guidelines. 5 All patients without an echocardiogram had relevant cardiac disease documented in their clinical record and NT-proBNP values higher than 1000 pg/ml.…”

Section: Study Design and Clinical Settingmentioning

confidence: 99%

“…1---4 Approximately 1-2% of the adult population in developed countries has HF, the prevalence rising to ≥10% among those 70 years of age or older. 1,5,6 In Portugal, the overall prevalence of chronic HF was 4.36% in a community-based epidemiological survey carried out in 1998, rising sharply with age; this was slightly higher than that of other European countries. 7 Across the globe, 17-45% of patients hospitalized with HF die within a year of hospitalization 3,4,8 and a quarter are rehospitalized within one month and up to two-thirds within a year.…”

Section: Introductionmentioning

confidence: 99%

“…2 Interest in this type of research has been growing in recent decades, for various reasons. 4 According to the latest guidelines on heart failure, the standard-of-care for HF patients recently hospitalized for acute de novo or chronic decompensated HF should include enrollment in a multidisciplinary care management program, 5,16 also known as a heart failure clinic. 17 The present study covers the year before the implementation of an HF clinic, using a multidisciplinary approach to HF patients, in a Portuguese tertiary university hospital.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Characteristics and outcomes of heart failure hospitalization before implementation of a heart failure clinic: The PRECIC study

Marques

Abreu

Bertão

et al. 2017

Revista Portuguesa de Cardiologia (English Edition)

View full text Add to dashboard Cite

Objective: This study aims to characterize patients hospitalized for acute heart failure (HF) in an internal medicine department and their one-year mortality and rate of rehospitalization for decompensated HF. Methods: This retrospective observational study enrolled all patients discharged in 2012 after hospitalization for acute HF. Discharge summaries, clinical records and telephone interviews were analysed. The data reports to the year before implementation of a heart failure clinic. Results: Four hundred and twenty-nine patients were enrolled, with a mean age of 79 years, 62.5% female. The most prevalent comorbidity and etiology was hypertension (86.7%) and the most frequent decompensation trigger was infection. HF with preserved ejection fraction (HFpEF) was present in 70.5%. In-hospital mortality was 7.9%. At discharge more than half of the patients were prescribed beta-blockers (52.8%) and angiotensin-converting enzyme inhibitors (52% FEp, p<0,001, respetivamente). No primeiro ano, a taxa de mortalidade foi 34,3% e de rehospitalização por IC 30,5%. Conclusões: A população estudada é idosa, predominantemente feminina e apresenta IC com FEp. Um terço morreu e/ou foi reinternada no ano seguinte. PALAVRAS-CHAVE

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Study Design and Clinical Settingmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Characteristics and outcomes of heart failure hospitalization before implementation of a heart failure clinic: The PRECIC study

Marques

Abreu

Bertão

et al. 2017

Revista Portuguesa de Cardiologia (English Edition)

View full text Add to dashboard Cite

show abstract

“…US imaging techniques to obtain rapid diagnoses in lung and heart emergencies have been developed, allowing for immediate treatment in case of acute respiratory [7], cardiac [8] and circulatory failures [9]. Undifferentiated hypotension in the emergency department should be guided by cardiac ultrasound after a standard 12-lead EKG has been obtained [10].…”

mentioning

confidence: 99%

Echography is mandatory for the initial management of critically ill patients: Yes

McLean

Lamperti²,

Poelaert

2014

Intensive Care Med

View full text Add to dashboard Cite

B-type natriuretic peptide-guided treatment for heart failure

McLellan

Heneghan

Perera

et al. 2016

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Background Heart failure is a condition in which the heart does not pump enough blood to meet all the needs of the body. Symptoms of heart failure include breathlessness, fatigue and fluid retention. Outcomes for patients with heart failure are highly variable; however on average, these patients have a poor prognosis. Prognosis can be improved with early diagnosis and appropriate use of medical treatment, use of devices and transplantation. Patients with heart failure are high users of healthcare resources, not only due to drug and device treatments, but due to high costs of hospitalisation care. B‐type natriuretic peptide levels are already used as biomarkers for diagnosis and prognosis of heart failure, but could offer to clinicians a possible tool to guide drug treatment. This could optimise drug management in heart failure patients whilst allaying concerns over potential side effects due to drug intolerance. Objectives To assess whether treatment guided by serial BNP or NT‐proBNP (collectively referred to as NP) monitoring improves outcomes compared with treatment guided by clinical assessment alone. Search methods Searches were conducted up to 15 March 2016 in the Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library; MEDLINE (OVID), Embase (OVID), the Database of Abstracts of Reviews of Effects (DARE) and the NHS Economic Evaluation Database in the Cochrane Library. Searches were also conducted in the Science Citation Index Expanded, the Conference Proceedings Citation Index on Web of Science (Thomson Reuters), World Health Organization International Clinical Trials Registry and ClinicalTrials.gov. We applied no date or language restrictions. Selection criteria We included randomised controlled trials of NP‐guided treatment of heart failure versus treatment guided by clinical assessment alone with no restriction on follow‐up. Adults treated for heart failure, in both in‐hospital and out‐of‐hospital settings, and trials reporting a clinical outcome were included. Data collection and analysis Two review authors independently selected studies for inclusion, extracted data and evaluated risk of bias. Risk ratios (RR) were calculated for dichotomous data, and pooled mean differences (MD) (with 95% confidence intervals (CI)) were calculated for continuous data. We contacted trial authors to obtain missing data. Using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, we assessed the quality of the evidence and GRADE profiler (GRADEPRO) was used to import data from Review Manager to create a 'Summary of findings' table. Main results We included 18 randomised controlled trials with 3660 participants (range of mean age: 57 to 80 years) comparing NP‐guided treatment with clinical assessment alone. The evidence for all‐cause mortality using NP‐guided treatment showed uncertainty (RR 0.87, 95% CI 0...

show abstract

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

Cited by 218 publications

References 236 publications

Characteristics and outcomes of heart failure hospitalization before implementation of a heart failure clinic: The PRECIC study

Characteristics and outcomes of heart failure hospitalization before implementation of a heart failure clinic: The PRECIC study

Echography is mandatory for the initial management of critically ill patients: Yes

B-type natriuretic peptide-guided treatment for heart failure

Contact Info

Product

Resources

About